PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Amiens-Picardie University Medical Center, Amiens, France.\', \'RECIF, Amiens-Picardie University Medical Center, Amiens, France.\', \'Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.\', \'MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France.\', \'Department of Rheumatology, Saint-Quentin Medical Center, Saint-Quentin, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/fcp.12695
?:hasPublicationType
?:journal
  • Fundamental & clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33973280
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all